TipRanks
pc:avenz

Avenzo Therapeutics

Avenzo Therapeutics is a clinical-stage biotechnology company based in San Diego, California, dedicated to developing next-generation oncology therapies. The company's pipeline includes potential best-in-class small molecules and antibody-drug conjugates (ADCs), targeting key enzymes involved in cell cycle regulation and specific cancer markers. Avenzo's lead drug candidates, including AVZO-021 and AVZO-023, are being studied for the treatment of advanced solid tumors and HR+/HER2- metastatic breast cancer, while its ADCs focus on bispecific targeting of cancer cells.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$60M
Total Amount Raised$60M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$60M
Latest Funding Amount$60M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 22, 2025
Series B
$60.00M
―

Investors

Investor Name
Funding Round
Series B
Series B
Series B

Similar Companies

A snapshot of private companies similar to Avenzo Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis